Showing results (111-120 of 347) with videos related to

Sort By:
Pageof 35
Kidney International|May 20, 2004
Differential effects of calcium antagonist subclasses on markers of nephropathy progressionGeorge L Bakris, Matthew R Weir, Michelle Secic, et al.
American Journal of Nephrology|October 11, 2017
Patiromer Lowers Serum Potassium When Taken without Food: Comparison to Dosing with Food from an Open-Label, Randomized, Parallel Group Hyperkalemia StudyPablo E Pergola, David M Spiegel, Suzette Warren, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|February 3, 2007
Evaluation of the dose response with valsartan and valsartan/hydrochlorothiazide in patients with essential hypertensionMatthew R Weir, Nora Crikelair, Drew Levy, et al.
Journal of the American Society of Nephrology : JASN|April 5, 2014
Assessment and management of hypertension in patients on dialysisRajiv Agarwal, Joseph Flynn, Velvie Pogue, et al.
Journal of the American Society of Hypertension : JASH|April 23, 2010
Antihypertensive efficacy, safety, and tolerability of the oral direct renin inhibitor aliskiren in patients with hypertension: a pooled analysisMatthew R Weir, Christopher Bush, David R Anderson, et al.
Advances in Therapy|December 28, 2020
Effect of Levothyroxine on Kidney Function in Chronic Kidney Disease with Subclinical Hypothyroidism in US Veterans: A Retrospective Observational Cohort StudyJames V Hennessey, Matthew R Weir, Seema Soni-Brahmbhatt, et al.
Journal of Diabetes and Its Complications|September 20, 2021
Effectiveness and safety of rivaroxaban versus warfarin among nonvalvular atrial fibrillation patients with obesity and diabetesMatthew R Weir, Yen-Wen Chen, Jinghua He, et al.
Diabetes, Obesity & Metabolism|August 31, 2021
Effects of canagliflozin on major adverse cardiovascular events by baseline estimated glomerular filtration rate: Pooled Hispanic subgroup analyses from the CANVAS Program and CREDENCE trialMatthew R Weir, Jagadish Gogate, C V Damaraju, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|October 26, 2021
Healthcare Resource Utilization and Costs of Rivaroxaban Versus Warfarin Among Nonvalvular Atrial Fibrillation Patients with Obesity and DiabetesMatthew R Weir, Yen-Wen Chen, Jinghua He, et al.
Future Cardiology|October 7, 2009
Albuminuria: pathophysiology, epidemiology and clinical relevance of an emerging marker for cardiovascular diseaseMartin Thoenes, Peter Bramlage, Bobby V Khan, et al.
Pageof 35